European Shares Struggle For Direction Ahead Of Fed Decision

European equities were subdued as investors awaited the Federal Reserve's rate decision expected to cut by 25 basis points on Wednesday and eyed a U.S. job‑openings report for clues on the labour market and the outlook for 2026. Economic data showed Germany's trade surplus widened to EUR 16.9 billion in October as exports rose 0.1% and imports fell 1.2%. The Stoxx 600 was marginally higher (+0.1%), the DAX gained 0.4% and the FTSE 100 slipped 0.1%, while stock‑specific moves included Chemring down >1% on higher Norwegian expansion costs, British American Tobacco off 4% after warning 2026 trading may sit at the lower end of its mid‑term targets, Nordex up 2.3% on new France/Belgium contracts and ThyssenKrupp plunging 7% after forecasting a potential EUR 800m net loss in 2026.

Analysis

European equities traded with muted direction as investors awaited the Federal Reserve's widely expected 25-basis-point rate cut on Wednesday and a U.S. job-openings report later in the day, with the pan-European Stoxx 600 edging up 0.1% to 579.03 while the DAX gained 0.4% and the FTSE 100 slipped 0.1%. The market tone reflects caution about the policy-path for 2026 despite a near-term easing move, consistent with the overall mildly negative sentiment score (-0.25) and a moderate market-impact score (0.35).

German macro data were mixed: the trade surplus widened to EUR 16.9 billion from EUR 15.3 billion as exports rose 0.1% (down from a 1.5% recovery in September) and imports fell 1.2% (after a 5.1% rise), signaling softer domestic demand that could weigh on eurozone cyclicals and industrial revenue visibility. These metrics suggest export resilience but potential headwinds to domestic-driven growth and order flows.

Company-specific moves amplified the caution: Chemring fell over 1% on higher Norwegian expansion costs, British American Tobacco tumbled 4% after warning 2026 trading may sit at the lower end of targets, Nordex rallied 2.3% on new France/Belgium contracts, and ThyssenKrupp plunged 7% after flagging a potential EUR 800 million net loss in 2026, introducing material earnings and balance-sheet risk for the industrial cohort.

Key Decisions for Investors

• Maintain reduced directional exposure into the Fed 25bp decision and the U.S. job-openings print and avoid initiating large new macro trades until post-data clarity emerges
• Underweight or avoid BAT and ThyssenKrupp until management provides clearer 2026 guidance and the implications of the EUR 800m loss are quantified
• Consider selective, modest long exposure to companies with confirmed contract wins (eg, Nordex) but size positions conservatively and monitor order-book/backlog detail
• Track subsequent German activity and U.S. labor data closely; if German domestic demand weakens further, rotate away from eurozone cyclicals and reassess beta and credit exposure